Nothing Special   »   [go: up one dir, main page]

DE69114922D1 - Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten. - Google Patents

Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.

Info

Publication number
DE69114922D1
DE69114922D1 DE69114922T DE69114922T DE69114922D1 DE 69114922 D1 DE69114922 D1 DE 69114922D1 DE 69114922 T DE69114922 T DE 69114922T DE 69114922 T DE69114922 T DE 69114922T DE 69114922 D1 DE69114922 D1 DE 69114922D1
Authority
DE
Germany
Prior art keywords
polysulfide compounds
contain
active ingredients
lipid peroxidation
peroxidation inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69114922T
Other languages
English (en)
Other versions
DE69114922T2 (de
Inventor
Shoji Awazu
Toshiharu Horie
Yukihiro Kodera
Shinji Nagae
Hiromichi Matsuura
Yoichi Itakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Publication of DE69114922D1 publication Critical patent/DE69114922D1/de
Application granted granted Critical
Publication of DE69114922T2 publication Critical patent/DE69114922T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/18—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69114922T 1990-06-22 1991-06-21 Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten. Expired - Fee Related DE69114922T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2165445A JP2963730B2 (ja) 1990-06-22 1990-06-22 ポリスルフィド化合物及びこれを有効成分とする脂質過酸化抑制剤

Publications (2)

Publication Number Publication Date
DE69114922D1 true DE69114922D1 (de) 1996-01-11
DE69114922T2 DE69114922T2 (de) 1996-07-25

Family

ID=15812567

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69114922T Expired - Fee Related DE69114922T2 (de) 1990-06-22 1991-06-21 Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.

Country Status (5)

Country Link
US (1) US5149879A (de)
EP (1) EP0464521B1 (de)
JP (1) JP2963730B2 (de)
AU (1) AU644002B2 (de)
DE (1) DE69114922T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728806A1 (de) * 1997-07-05 1999-01-07 Rhein Chemie Rheinau Gmbh Geschwefelte unverzweigte Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
FR2831447B1 (fr) 2001-10-26 2004-03-12 Innovaderm Absolues de bulbes d'allium sativum et utilisations a titre therapeutique ou cosmetique
JP5414529B2 (ja) * 2006-11-11 2014-02-12 エコスプレイ リミテッド ニンニクの処理
US20080318864A1 (en) * 2007-06-25 2008-12-25 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
WO2009055677A1 (en) * 2007-10-24 2009-04-30 University Of South Florida Antibacterial s-heterosubstituted disulfides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3103465A (en) * 1963-09-10 Bird repellent composition
DE1198352B (de) * 1962-02-20 1965-08-12 Woelm Fa M Verfahren zur Herstellung von Di-n-alkylpentasulfiden
US3163465A (en) * 1963-06-20 1964-12-29 Faulhaber Company Cycle saddle
JPS57209218A (en) * 1981-06-19 1982-12-22 Nippon Arukon Kk Antithrombotic
FR2550193A1 (fr) * 1983-08-05 1985-02-08 Sal Fine Chemicals Internation Complexes d'inclusion de trisulfure de methyle et d'allyle avec des cyclodextrines, leur procede de preparation et compositions pharmaceutiques les contenant
JPS60258157A (ja) * 1984-06-02 1985-12-20 Riken Kagaku Kogyo Kk トリサルファイド化合物の製造法
FR2607496B1 (fr) * 1986-11-28 1989-03-10 Elf Aquitaine Procede de production de polysulfures organiques et systeme catalytique pour sa realisation
US4804485A (en) * 1987-05-08 1989-02-14 Pennwalt Corporation Polyalkyleneoxyamine catalysts for dialkyl disulfides and/or polysulfides used in dissolving sulfur
JPS6419057A (en) * 1987-07-14 1989-01-23 Nippon Mektron Kk Allyl(1-propenyl) disulfide and production thereof
FR2635775B1 (fr) * 1988-08-23 1990-11-23 Elf Aquitaine Synthese de polysulfures organiques

Also Published As

Publication number Publication date
EP0464521A2 (de) 1992-01-08
JPH0454117A (ja) 1992-02-21
EP0464521A3 (en) 1992-07-22
EP0464521B1 (de) 1995-11-29
AU644002B2 (en) 1993-12-02
JP2963730B2 (ja) 1999-10-18
AU7847791A (en) 1992-01-02
DE69114922T2 (de) 1996-07-25
US5149879A (en) 1992-09-22

Similar Documents

Publication Publication Date Title
DE69711640D1 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
DE69101080D1 (de) Diätfaser, Verfahren und physiologische aktive Zusammensetzung, die diese als aktives Ingredient enhält.
ATE38232T1 (de) Metallocene und photopolymerisierbare zusammensetzung, enthaltend diese metallocene.
DE3881443D1 (de) Imidazol-verbindung und diese enthaltende biozide zusammensetzungen.
DE3852229D1 (de) Metalle der Platingruppe enthaltende Mikrokapsel und Zusammensetzungen, die diese enthalten.
DE3869114D1 (de) Fluessigkristallverbindung und gemische, die diese verbindung enthalten.
DE69832171D1 (de) Derivate des 4-chinolols und land- und gartenbauwirtschaftliche bakterizide, die diese als aktiven bestandteil enthalten
DE3688011D1 (de) Schmiermittelzusammensetzungen, neue glucamin-derivate und diese enthaltende komplexverbindungen.
NL193819B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
ATE81505T1 (de) Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
DE68914495D1 (de) Antihypercholesterolemisches Mittel.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ATE250570T1 (de) Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten
DE69114922D1 (de) Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.
DE69002533D1 (de) Indan-1,3-dionderivate und herbizide zusammensetzungen, die diese als aktiven bestandteil enthalten.
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
DE68905171D1 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE69401151D1 (de) Indenderivate und antimikrobe Mittel, die diese Indenderivate als Aktivkomponente enthalten
DE69010754D1 (de) Fungizide Mittel.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
NO900564D0 (no) Overflateaktivt middel.
DE69301261D1 (de) Indan-1,3-Dionderivate und Herbizide, die diese als aktiven Bestandteil enthalten
DE69009823D1 (de) Zusammensetzungen, die 2-Thiocyanomethylthiobenzothiazol enthalten.
DE69007956D1 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee